Quick Takeaways
- David R. Guyer has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $18,619.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David R. Guyer
- Location
- New York, NY
- Summary
- The estimated net worth of David R. Guyer is at least $18,619 dollars as of 16 Jul 2024. David R. Guyer is the Director of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint, Inc. (EYPT) stock worth about $18.6K.
- Signature
- /s/ Ron Honig, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David R. Guyer and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: EyePoint Pharmaceuticals, Inc. ($18,619).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David R. Guyer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals, Inc. | Director | $18,619 | 12 Jul 2024 |
Insider Transactions Reported by David R. Guyer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.